These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17310512)

  • 1. Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?
    Ames D; Ritchie C
    Int Psychogeriatr; 2007 Feb; 19(1):1-8. PubMed ID: 17310512
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin E and Alzheimer disease: the basis for additional clinical trials.
    Grundman M
    Am J Clin Nutr; 2000 Feb; 71(2):630S-636S. PubMed ID: 10681271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Sano M; Ernesto C; Thomas RG; Klauber MR; Schafer K; Grundman M; Woodbury P; Growdon J; Cotman CW; Pfeiffer E; Schneider LS; Thal LJ
    N Engl J Med; 1997 Apr; 336(17):1216-22. PubMed ID: 9110909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Alzheimer's disease -- searching for a breakthrough, settling for less.
    Drachman DA; Leber P
    N Engl J Med; 1997 Apr; 336(17):1245-7. PubMed ID: 9110915
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic actions of L-deprenyl in dogs: a model of human brain aging.
    Ruehl WW; Neilson J; Hart B; Head E; Bruyette DS; Cummings BJ
    Adv Pharmacol; 1998; 42():316-9. PubMed ID: 9327904
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monoamine oxidase inhibitors: prospects for the use in clinical practice].
    Evtushenko SK; Lutskiĭ IS; Efimenko VN; Kazarian NE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(8):53-60. PubMed ID: 12233260
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of deprenyl and thiotic acid in HIV-associated cognitive impairment.
    Roesler R; Quevedo J; Walz R; Bianchin M
    Neurology; 1999 Jun; 52(9):1920-1. PubMed ID: 10371554
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of deprenyl and thiotic acid in HIV-associated cognitive impairment.
    Di Rocco A
    Neurology; 1999 Jun; 52(9):1920; author reply 1920-1. PubMed ID: 10371553
    [No Abstract]   [Full Text] [Related]  

  • 9. Free radicals in Alzheimer's dementia: currently available therapeutic strategies.
    Rösler M; Retz W; Thome J; Riederer P
    J Neural Transm Suppl; 1998; 54():211-9. PubMed ID: 9850930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mechanisms of action of (-)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders.
    Berry MD; Juorio AV; Paterson IA
    Prog Neurobiol; 1994 Oct; 44(2):141-61. PubMed ID: 7831475
    [No Abstract]   [Full Text] [Related]  

  • 11. Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E.
    Fillenbaum GG; Kuchibhatla MN; Hanlon JT; Artz MB; Pieper CF; Schmader KE; Dysken MW; Gray SL
    Ann Pharmacother; 2005 Dec; 39(12):2009-14. PubMed ID: 16227448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAO-B inhibitors for the treatment of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S38-44. PubMed ID: 12211138
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of monoamine oxidase-B by selegiline reduces cigarette smoke-induced oxidative stress and inflammation in airway epithelial cells.
    Cui Y; Liu KW; Liang Y; Ip MS; Mak JC
    Toxicol Lett; 2017 Feb; 268():44-50. PubMed ID: 28108387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study suggests antioxidants slow decline in Alzheimer's disease.
    Am J Health Syst Pharm; 1997 Jul; 54(13):1478, 1481. PubMed ID: 9217935
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin C and vitamin E for Alzheimer's disease.
    Boothby LA; Doering PL
    Ann Pharmacother; 2005 Dec; 39(12):2073-80. PubMed ID: 16227450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase-B inhibitors in the treatment of Alzheimer's disease.
    Thomas T
    Neurobiol Aging; 2000; 21(2):343-8. PubMed ID: 10867219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncholinergic treatment options for Alzheimer's disease.
    Sano M
    J Clin Psychiatry; 2003; 64 Suppl 9():23-8. PubMed ID: 12934971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant vitamins E and C and risk of Alzheimer's disease.
    Martin A
    Nutr Rev; 2003 Feb; 61(2):69-73. PubMed ID: 12674439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin E on cognitive performance during ageing and in Alzheimer's disease.
    La Fata G; Weber P; Mohajeri MH
    Nutrients; 2014 Nov; 6(12):5453-72. PubMed ID: 25460513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.